BioCentury | Jun 19, 2008
Distillery Therapeutics

This Week in Therapeutics

...contact information Cancer Acute myelogenous leukemia (AML); leukemia; multiple myeloma (MM) Cyclin D1 (CCND1; BCL1); cyclin D2 (CCND2)...
BioCentury | May 8, 2008
Distillery Therapeutics

This Week in Therapeutics

...Target/marker/pathway Summary Licensing status Publication and contact information Cancer Multiple myeloma (MM) Cyclin D1 (CCND1); cyclin D2 (CCND2)...
Items per page:
1 - 2 of 2